Cargando…

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors

Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Onyılmaz, Mehmet, Koca, Murat, Bonardi, Alessandro, Degirmenci, Mustafa, Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865125/
https://www.ncbi.nlm.nih.gov/pubmed/35188025
http://dx.doi.org/10.1080/14756366.2022.2041630
_version_ 1784655588104339456
author Onyılmaz, Mehmet
Koca, Murat
Bonardi, Alessandro
Degirmenci, Mustafa
Supuran, Claudiu T.
author_facet Onyılmaz, Mehmet
Koca, Murat
Bonardi, Alessandro
Degirmenci, Mustafa
Supuran, Claudiu T.
author_sort Onyılmaz, Mehmet
collection PubMed
description Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-substituted pyrimidine trione/thioxo-pyrimidine dione moieties were investigated for their interaction with four human (h) CA isoforms, hCA I, II, IX and XII, known to be important drug targets. hCA I and II were not inhibited by these compounds, whereas hCA IX and XII were inhibited in the low micromolar range by the less bulky derivatives. The inhibition constants ranged between 2.7–78.9 µM against hCA IX and of 1.2–66.5 µM against hCA XII. As for the coumarins, we hypothesise that the isocoumarins are hydrolysed by the esterase activity of the enzyme with formation of 2-carboxy-phenylacetic aldehydes which act as CA inhibitors. Isocoumarins represent a new class of CA inhibitors.
format Online
Article
Text
id pubmed-8865125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88651252022-02-24 Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors Onyılmaz, Mehmet Koca, Murat Bonardi, Alessandro Degirmenci, Mustafa Supuran, Claudiu T. J Enzyme Inhib Med Chem Brief Report Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-substituted pyrimidine trione/thioxo-pyrimidine dione moieties were investigated for their interaction with four human (h) CA isoforms, hCA I, II, IX and XII, known to be important drug targets. hCA I and II were not inhibited by these compounds, whereas hCA IX and XII were inhibited in the low micromolar range by the less bulky derivatives. The inhibition constants ranged between 2.7–78.9 µM against hCA IX and of 1.2–66.5 µM against hCA XII. As for the coumarins, we hypothesise that the isocoumarins are hydrolysed by the esterase activity of the enzyme with formation of 2-carboxy-phenylacetic aldehydes which act as CA inhibitors. Isocoumarins represent a new class of CA inhibitors. Taylor & Francis 2022-02-21 /pmc/articles/PMC8865125/ /pubmed/35188025 http://dx.doi.org/10.1080/14756366.2022.2041630 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Onyılmaz, Mehmet
Koca, Murat
Bonardi, Alessandro
Degirmenci, Mustafa
Supuran, Claudiu T.
Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title_full Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title_fullStr Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title_full_unstemmed Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title_short Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
title_sort isocoumarins: a new class of selective carbonic anhydrase ix and xii inhibitors
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865125/
https://www.ncbi.nlm.nih.gov/pubmed/35188025
http://dx.doi.org/10.1080/14756366.2022.2041630
work_keys_str_mv AT onyılmazmehmet isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors
AT kocamurat isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors
AT bonardialessandro isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors
AT degirmencimustafa isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors
AT supuranclaudiut isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors